ATHA
Price:
$0.5414
Market Cap:
$20.81M
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical trials for the treatment of Alzheimer's disease, as well as is in Phase 2 clinical trials to treat Parkinson's disease. It also develops product candidates, which are in preclinical stage, including ATH-1019 for peripheral nervous system indications; and ATH-1020 for neuropsychiatric conditions. Athira Pharma, Inc. was formerly known as M3 Biotechnology,...[Read more]
Industry
Biotechnology
IPO Date
2020-09-18
Stock Exchange
NASDAQ
Ticker
ATHA
According to Athira Pharma, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.18. This represents a change of -77.79% compared to the average of -0.81 of the last 4 quarters.
The mean historical PE Ratio of Athira Pharma, Inc. over the last ten years is -35.03. The current -0.18 PE Ratio has changed -48.62% with respect to the historical average. Over the past ten years (40 quarters), ATHA's PE Ratio was at its highest in in the September 2023 quarter at -0.58. The PE Ratio was at its lowest in in the June 2020 quarter at -61.87.
Average
-35.03
Median
-14.81
Minimum
-118.70
Maximum
-0.79
Discovering the peaks and valleys of Athira Pharma, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 471.55%
Maximum Annual PE Ratio = -0.79
Minimum Annual Increase = -85.18%
Minimum Annual PE Ratio = -118.70
Year | PE Ratio | Change |
---|---|---|
2023 | -0.79 | -42.72% |
2022 | -1.37 | -84.51% |
2021 | -8.85 | -85.18% |
2020 | -59.71 | -49.70% |
2019 | -118.70 | 471.55% |
The current PE Ratio of Athira Pharma, Inc. (ATHA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.67
5-year avg
-37.88
10-year avg
-35.03
Athira Pharma, Inc.’s PE Ratio is less than CytomX Therapeutics, Inc. (9.19), less than Spero Therapeutics, Inc. (4.06), greater than Neoleukin Therapeutics, Inc. (-0.98), greater than Instil Bio, Inc. (-0.78), greater than NextCure, Inc. (-0.65), greater than Assembly Biosciences, Inc. (-2.10), greater than Achilles Therapeutics plc (-0.45), greater than Nuvation Bio Inc. (-1.34),
Company | PE Ratio | Market cap |
---|---|---|
9.19 | $93.74M | |
4.06 | $71.07M | |
-0.98 | $8.20M | |
-0.78 | $92.68M | |
-0.65 | $39.73M | |
-2.10 | $107.81M | |
-0.45 | $29.58M | |
-1.34 | $692.60M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Athira Pharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Athira Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Athira Pharma, Inc.'s PE Ratio?
How is the PE Ratio calculated for Athira Pharma, Inc. (ATHA)?
What is the highest PE Ratio for Athira Pharma, Inc. (ATHA)?
What is the 3-year average PE Ratio for Athira Pharma, Inc. (ATHA)?
What is the 5-year average PE Ratio for Athira Pharma, Inc. (ATHA)?
How does the current PE Ratio for Athira Pharma, Inc. (ATHA) compare to its historical average?